Sunshine Biopharma Inc. Quarterly Current Ratio in % from Q2 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Sunshine Biopharma Inc. quarterly Current Ratio history and growth rate from Q2 2016 to Q3 2024.
  • Sunshine Biopharma Inc. Current Ratio for the quarter ending September 30, 2024 was 481 %, a 9.35% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 481 +41.2 +9.35% Sep 30, 2024
Q2 2024 467 -161 -25.7% Jun 30, 2024
Q1 2024 482 -455 -48.5% Mar 31, 2024
Q4 2023 457 -1.17K -71.9% Dec 31, 2023
Q3 2023 440 -12.3K -96.6% Sep 30, 2023
Q2 2023 628 -7.25K -92% Jun 30, 2023
Q1 2023 937 -601 -39.1% Mar 31, 2023
Q4 2022 1.62K +1.22K +302% Dec 31, 2022
Q3 2022 12.8K +12.5K +5287% Sep 30, 2022
Q2 2022 7.88K +7.72K +4899% Jun 30, 2022
Q1 2022 1.54K +1.43K +1332% Mar 31, 2022
Q4 2021 404 +350 +654% Dec 31, 2021
Q3 2021 237 +212 +847% Sep 30, 2021
Q2 2021 158 +147 +1414% Jun 30, 2021
Q1 2021 107 +99.2 +1207% Mar 31, 2021
Q4 2020 53.6 +40.9 +322% Dec 31, 2020
Q3 2020 25 -14.3 -36.4% Sep 30, 2020
Q2 2020 10.4 -31.5 -75.2% Jun 30, 2020
Q1 2020 8.22 -34.7 -80.8% Mar 31, 2020
Q4 2019 12.7 -28.8 -69.4% Dec 31, 2019
Q3 2019 39.4 +21.9 +125% Sep 30, 2019
Q2 2019 42 +22.5 +116% Jun 30, 2019
Q1 2019 42.9 +23.2 +118% Mar 31, 2019
Q4 2018 41.5 +22.1 +114% Dec 31, 2018
Q3 2018 17.5 -3.65 -17.3% Sep 30, 2018
Q2 2018 19.4 +4.78 +32.7% Jun 30, 2018
Q1 2018 19.7 +7.5 +61.4% Mar 31, 2018
Q4 2017 19.4 +3.84 +24.7% Dec 31, 2017
Q3 2017 21.1 +9.62 +83.6% Sep 30, 2017
Q2 2017 14.6 +0.92 +6.71% Jun 30, 2017
Q1 2017 12.2 Mar 31, 2017
Q4 2016 15.6 Dec 31, 2016
Q3 2016 11.5 Sep 30, 2016
Q2 2016 13.7 Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.